In a landmark ruling on Tuesday, a UK court has determined that children under the age of 16 will require court approval to access puberty blockers, igniting
In a landmark ruling on Tuesday, a UK court has determined that children under the age of 16 will require court approval to access puberty blockers, igniting a global debate about the appropriate age for a child to make decisions regarding gender transition. Three judges from the High Court stated that it was highly unlikely for children aged 13 or younger to be competent to give consent for puberty blockers, while also expressing doubts about the ability of 14- and 15-year-olds to weigh the long-term risks and consequences associated with such treatment. Following the ruling, the National Health Service (NHS) England updated its guidelines, stipulating that a court order must be obtained for any new referral seeking medication related to puberty blockers. The Tavistock and Portman NHS Foundation Trust, which operates England's sole youth gender identity clinic, has pledged to appeal the decision, setting the stage for a potential showdown in the Supreme Court.











